Clinical Trial Update: Hemoperfusion Efferon LPS During Cardiac Surgery Using Cardiopulmonary Bypass [NA]

View source ↗

Summary

The clinical trial evaluating hemoperfusion with Efferon LPS during cardiac surgery using cardiopulmonary bypass has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Multiple Organ Dysfunction Syndrome

Drugs mentioned

• Efferon LPS

Snippet

Sponsor: Efferon JSC | Conditions: Cardiac Disease, Multiple Organ Dysfunction Syndrome | NA | Status: TERMINATED